key: cord-0938487-sndd83jv
authors: Soriano, Vicente; de Mendoza, Carmen; Gómez-Gallego, Felix; Corral, Octavio; Barreiro, Pablo
title: Third wave of COVID-19 in Madrid, Spain
date: 2021-04-27
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.04.074
sha: 9295cb8158548d3d349e7d989e96d4a06894efae
doc_id: 938487
cord_uid: sndd83jv

A third wave of COVID-19 occurred after Christmas in Madrid, one of the European epicenters. We noticed six major differential features. First, household contacts were a large proportion of cases. Second, access to rapid antigen tests allowed prompt diagnosis and isolation. Third, clinically severe cases and mortality rates were lower than in prior waves. Fourth, the more transmissible B.1.1.7 strain was increasingly found. Fifth, vaccination benefits were seen in health care workers and nursing homes. Lastly, re-infections were more common. Before Easter, roughly 25% of the population in Madrid had been infected with SARS-CoV-2. Therefore, massive and accelerated vaccination campaigns are warranted to prevent new COVID-19 waves.

Madrid has been the epicenter of COVID-19 in Spain, largely due to its high population density and frequent mobility flows. The city has 3.3 million people but the metropolitan area rises up to 6.8 million. Up to March 15 th , roughly 605,000 persons had been diagnosed with SARS-CoV-2 infection and 14,000 had died in the Madrid region [Ministerio de Sanidad, 2021; Instituto Nacional de Estadística, 2021] . These figures refer to laboratory confirmed cases, which is an underestimation of the real number, since testing access was limited during the earlier stages of the pandemic .

Two major waves of COVID-19 had occurred in Madrid during year 2020. The first during the spring, peaked in March-April and the second in September-October. Their main features have already been described elsewhere Pollán, 2020; Soriano, 2021 b ]. Following holidays and family gatherings during Christmas, a third wave was noticed in January-February of year 2021. Herein, we report the major differential characteristics of this new surge.

A nationwide register of SARS-CoV-2 infections and deaths exist in Spain since March 2020.

Regional autonomic regions contribute to update the database on a daily basis [Ministerio de Sanidad, 2021; Instituto Nacional de Estadística, 2021] . For the purpose of this study, we examined and analyzed the registers belonging to the Comunidad Autónoma de Madrid from March 1 st 2020 to March 15 th 2021.

The first confirmed cases of SARS-CoV-2 infection and deaths due to COVID-19 in Madrid were reported in March 2020. Figure 1 records the evolution of daily reported cases and deaths in Madrid due to SARS-CoV-2 infection since the beginning of the pandemic. The three major waves last for 1-2 months each. The first wave occurred during the spring of 2020, the second wave during fall of 2020, and the third wave in January-February of 2021.

After two waves of COVID-19 during spring and fall of 2020, a third wave emerged during early 2021. This new COVID-19 surge had six major differential features. First, a larger proportion of cases were linked to household contacts, most likely because Christmas gatherings were the major trigger of this new wave [Thompson, 2021] . Second, the widespread use of rapid antigen tests allowed prompt diagnosis and isolation of many positive individuals (Soriano, 2020 b ). Third, the proportion of clinically severe cases and mortality rates were lower compared to prior COVID-19 waves. Fourth, the more transmissible virus strain B.1.1.7 was increasingly represented. Fifth, the impact of vaccination was recognized among certain groups, mostly health care workers and elderly people at nursing homes. Lastly, a growing proportion of cases presumably represented re-infections in people that already had been positive for the virus using PCR testing and/or being seroreactive for antibodies.

The proportion of clinically severe cases of SARS-CoV-2 infection has declined since the first wave, most likely because diagnoses of asymptomatic or mild symptomatic individuals has J o u r n a l P r e -p r o o f increased over time. In this regard, the widespread use of rapid tests in recent times has allowed more prompt isolation [Soriano, 2020 b ] as well as better clinical monitoring and treatment of carriers [Griffin, 2021; . Indeed, almost all individuals with arterial oxygen saturation values going below 93% begun being treated with corticosteroids. The proportion of hospitalizations and mortality rates in the latest wave have declined compared to the first wave along with huge increases in diagnostic capacity. As survivors following hospital discharges are now a huge number, an outclinic devoted to follow periodically these patients has been established, and those fulfilling criteria for long-COVID have begun to be closely examined.

The role of lower inoculum size as cause of less severe clinical presentations and lower mortality rates during the third wave is an alternative explanation [Guallar, 2020] . It reflects indirectly the benefit of universal 'social distancing', including facial masking, outdoor activities and gathering restrictions.

Since Christmas, a growing proportion of new SARS-CoV-2 infections in Madrid are due to the B.1.1.7 strain, that nowadays account for more than one third of infections. The forces of evolution will not stop as we begin to approach herd immunity and loosen restrictions. A combination of mutations in the B.1.1.7 strain make it especially contagious, whereas the B.1.351 variant can evade antibodies because of E484K . History tells us that viruses can evolve rapidly to evade barriers to transmission, especially when infections remain numerous. We must remember that the more infections there are, the more chance mutations will occur, and those that best help the virus to survive will proliferate.

The importance of understanding the stages of COVID-19 in treatment and trials

Inoculum at the time of SARS-CoV-2 exposure and risk of disease severity

The time to offer treatments for COVID-19

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Why such excess of mortality for COVID-19 in Spain?

Rapid antigen testing and mask wearing while waiting for COVID-19 vaccines

Severe Acute Respiratory Syndrome Coronavirus 2 antibodies in adults in

Main differences between the first and second waves of COVID-19 in Madrid, Spain

New SARS-CoV-2 variants challenge vaccines protection

SARS-CoV-2 settingspecific transmission rates: a systematic review and meta-analysis

The authors thank the staff of the UNIR Medical Centre and of Consejería de Sanidad de Madrid for providing access to information recorded by the regional public health system. J o u r n a l P r e -p r o o f